INHBE and pancreatic neoplasm: It was recently shown that muscle-specific blockade of myostatin and activins by use of skeletal muscle-specific dominant negative ACVR2B-expressing transgenic mice did not improve survival with orthotopic pancreatic tumors originated from activin A high cell lines, despite the maintenance of body mass [146].